Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Interest & Investment Income: 2023-2024

Historic Interest & Investment Income for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $26.6 million.

  • CG Oncology's Interest & Investment Income fell 5.97% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.7 million, marking a year-over-year increase of 23.94%. This contributed to the annual value of $26.6 million for FY2024, which is 285.63% up from last year.
  • Latest data reveals that CG Oncology reported Interest & Investment Income of $26.6 million as of FY2024, which was up 285.63% from $6.9 million recorded in FY2023.
  • In the past 5 years, CG Oncology's Interest & Investment Income registered a high of $26.6 million during FY2024, and its lowest value of $6.9 million during FY2023.
  • In the last 2 years, CG Oncology's Interest & Investment Income had a median value of $16.8 million in 2023 and averaged $16.8 million.
  • Data for CG Oncology's Interest & Investment Income shows a peak YoY skyrocketed of 285.63% (in 2024) over the last 5 years.
  • CG Oncology's Interest & Investment Income (Yearly) stood at $6.9 million in 2023, then skyrocketed by 285.63% to $26.6 million in 2024.